Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244309
Status:
COMPLETED
Last Update Posted:
2011-05-04
First Post:
2005-10-24
Brief Title:
Study of Tamsulosin andor Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Study Overview
Official Title:
A Randomized Trial of Tamsulosin andor Dutasteride Versus Placebo to Relieve Urinary Symptoms After Brachytherapy for the Treatment of Localized Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether a drug named tamsulosin Flomax or another drug named dutasteride Avodart or a combination of these two drugs is effective in improving urinary symptoms and decreasing the rate of intermittent self-catheterization after prostate brachytherapy
Detailed Description:
Image-guided transperineal permanent prostate brachytherapy PI is an accepted curative treatment option for patients with early stage prostate cancer The most severe side effect of PI is urinary retention requiring intermittent self-catheterization ISC This study will assess the ability of pharmacologic intervention to ameliorate the post-operative side effect of PI The use of both tamsulosin and dutasteride is proposed to have benefit in reducing urinary symptom score and in reducing the rate of intermittent self-catheterization for patients with prostate adenocarcinoma after prostate implant
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GSK106046 formerly 103988 | None | None | None |